Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387420789> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4387420789 endingPage "4155" @default.
- W4387420789 startingPage "4147" @default.
- W4387420789 abstract "Based on the androgen receptor(AR)/mammalian target of rapamycin(mTOR)signaling pathway, the effects of Xihuang Pills-medicated serum on the proliferation and apoptosis of prostate cancer LNCaP cells were investigated. The drug-containing serum of SD rats was prepared by intragastric administration of Xihuang Pills suspension. The effects of low-, medium-, and high-dose Xihuang Pills-containing serum on the in vitro proliferation of LNCaP cells were detected by cell counting kit-8(CCK-8). Flow cytometry was used to detect the apoptosis level of LNCaP cells after intervention with different concentrations of Xihuang Pills. Protein expression of cleaved cysteinyl aspartate-specific proteinase caspase-3(cleaved caspase-3), B-cell lymphoma-2(Bcl-2), and AR as well as the phosphorylation level of mTOR protein were detected by Western blot. The results showed that compared with the blank serum, the drug-medicated serum could blunt the activity of LNCaP cells. Low-, medium-, and high-dose Xihuang Pills-containing serum could significantly increase the cell apoptosis rate, increase the expression of cleaved caspase-3 protein, decrease the expression of Bcl-2 protein, reduce the expression of AR protein, and down-regulate the level of phosphorylated mTOR(p-mTOR). To study the effect of Xihuang Pills on the growth of LNCaP cells in vivo, different doses of Xihuang Pills were used to intervene in the subcutaneous graft model in nude mice inoculated with LNCaP cells. The expression levels of AR, mTOR, p-mTOR, Bcl-2, and cleaved caspase-3 were detected by Western blot. The results showed that the volumes of subcutaneous graft tumor in the low-dose, medium-dose, and high-dose Xihuang Pills groups significantly decreased compared with that in the model group. The weight of subcutaneous transplanted tumor in each group with drug intervention was significantly lower than that in the model group. Compared with the model group, the low-dose, medium-dose, and high-dose Xihuang Pills groups showed increased cleaved caspase-3 protein expression, decreased Bcl-2 and AR protein expression, and reduced p-mTOR protein expression. Further experiments showed that AR agonist R1881 could block the anti-proliferation and pro-apoptotic effects of Xihuang Pills. The mechanism of Xihuang Pills against prostate cancer is related to the inhibition of the AR/mTOR signaling pathway, inhibition of LNCaP cell proliferation, and induction of apoptosis in cancer cells." @default.
- W4387420789 created "2023-10-08" @default.
- W4387420789 creator A5001260120 @default.
- W4387420789 creator A5002500632 @default.
- W4387420789 creator A5008830671 @default.
- W4387420789 creator A5016887977 @default.
- W4387420789 creator A5022863903 @default.
- W4387420789 creator A5031991387 @default.
- W4387420789 creator A5035955389 @default.
- W4387420789 creator A5036294961 @default.
- W4387420789 creator A5054860839 @default.
- W4387420789 creator A5080951657 @default.
- W4387420789 date "2023-08-01" @default.
- W4387420789 modified "2023-10-18" @default.
- W4387420789 title "[Effects of Xihuang Pills on proliferation and apoptosis of prostate cancer LNCaP cells based on AR/m TOR signaling pathway]." @default.
- W4387420789 doi "https://doi.org/10.19540/j.cnki.cjcmm.20230518.701" @default.
- W4387420789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37802783" @default.
- W4387420789 hasPublicationYear "2023" @default.
- W4387420789 type Work @default.
- W4387420789 citedByCount "0" @default.
- W4387420789 crossrefType "journal-article" @default.
- W4387420789 hasAuthorship W4387420789A5001260120 @default.
- W4387420789 hasAuthorship W4387420789A5002500632 @default.
- W4387420789 hasAuthorship W4387420789A5008830671 @default.
- W4387420789 hasAuthorship W4387420789A5016887977 @default.
- W4387420789 hasAuthorship W4387420789A5022863903 @default.
- W4387420789 hasAuthorship W4387420789A5031991387 @default.
- W4387420789 hasAuthorship W4387420789A5035955389 @default.
- W4387420789 hasAuthorship W4387420789A5036294961 @default.
- W4387420789 hasAuthorship W4387420789A5054860839 @default.
- W4387420789 hasAuthorship W4387420789A5080951657 @default.
- W4387420789 hasConcept C104317684 @default.
- W4387420789 hasConcept C121608353 @default.
- W4387420789 hasConcept C126322002 @default.
- W4387420789 hasConcept C134018914 @default.
- W4387420789 hasConcept C153911025 @default.
- W4387420789 hasConcept C185592680 @default.
- W4387420789 hasConcept C190283241 @default.
- W4387420789 hasConcept C2776415932 @default.
- W4387420789 hasConcept C2779723316 @default.
- W4387420789 hasConcept C2780192828 @default.
- W4387420789 hasConcept C502942594 @default.
- W4387420789 hasConcept C553184892 @default.
- W4387420789 hasConcept C55493867 @default.
- W4387420789 hasConcept C62112901 @default.
- W4387420789 hasConcept C71924100 @default.
- W4387420789 hasConcept C86554907 @default.
- W4387420789 hasConcept C86803240 @default.
- W4387420789 hasConceptScore W4387420789C104317684 @default.
- W4387420789 hasConceptScore W4387420789C121608353 @default.
- W4387420789 hasConceptScore W4387420789C126322002 @default.
- W4387420789 hasConceptScore W4387420789C134018914 @default.
- W4387420789 hasConceptScore W4387420789C153911025 @default.
- W4387420789 hasConceptScore W4387420789C185592680 @default.
- W4387420789 hasConceptScore W4387420789C190283241 @default.
- W4387420789 hasConceptScore W4387420789C2776415932 @default.
- W4387420789 hasConceptScore W4387420789C2779723316 @default.
- W4387420789 hasConceptScore W4387420789C2780192828 @default.
- W4387420789 hasConceptScore W4387420789C502942594 @default.
- W4387420789 hasConceptScore W4387420789C553184892 @default.
- W4387420789 hasConceptScore W4387420789C55493867 @default.
- W4387420789 hasConceptScore W4387420789C62112901 @default.
- W4387420789 hasConceptScore W4387420789C71924100 @default.
- W4387420789 hasConceptScore W4387420789C86554907 @default.
- W4387420789 hasConceptScore W4387420789C86803240 @default.
- W4387420789 hasIssue "15" @default.
- W4387420789 hasLocation W43874207891 @default.
- W4387420789 hasOpenAccess W4387420789 @default.
- W4387420789 hasPrimaryLocation W43874207891 @default.
- W4387420789 hasRelatedWork W1888950333 @default.
- W4387420789 hasRelatedWork W2023041974 @default.
- W4387420789 hasRelatedWork W2032373764 @default.
- W4387420789 hasRelatedWork W2152536832 @default.
- W4387420789 hasRelatedWork W2343596771 @default.
- W4387420789 hasRelatedWork W2363336275 @default.
- W4387420789 hasRelatedWork W2367983981 @default.
- W4387420789 hasRelatedWork W2376586311 @default.
- W4387420789 hasRelatedWork W2379794633 @default.
- W4387420789 hasRelatedWork W4226530757 @default.
- W4387420789 hasVolume "48" @default.
- W4387420789 isParatext "false" @default.
- W4387420789 isRetracted "false" @default.
- W4387420789 workType "article" @default.